3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 1
3
Phase 3
2
Phase 4
1
Status
Recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Myeloid
2
Conditions
Polycythemia Vera
2
Interventions
Carboplatin
129
pembrolizumab
124
Cisplatin
114
Paclitaxel
102
Gemcitabine
85
Specimen Handling
80
Magnetic Resonance Spectroscopy
80
Docetaxel
70
Dexamethasone
59
Cyclophosphamide
59
Pemetrexed
55
Bevacizumab
54
durvalumab
53
Doxorubicin
52
Radiotherapy
49
Capecitabine
49
Radiation
47
Oxaliplatin
47
Fluorouracil
47
Rituximab
42
Leucovorin
42
Vincristine
41
Lenalidomide
40
Etoposide
38
Letrozole
36
atezolizumab
35
Nivolumab
35
Prednisone
31
Bortezomib
31
130-nm albumin-bound paclitaxel
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Hydroxyurea
×
90 days
×
Clear all
NCT04116502
2026-04-28
MITHRIDATE
University of Birmingham
Phase 3
Recruiting
586 enrolled
NCT06093672
2026-03-25
GIV-IN-PV
Italfarmaco
Phase 3
Recruiting
220 enrolled